CaseBioscience® Launches CaseBio™ Culture and CaseBio™ Handling Media at ASRM 2025 After FDA 510(k) Clearance and Clinical Evaluation

Reflecting years of stem cell research and innovation in assisted reproductive technology, CaseBioscience® advances ART through the science of stem cells—uniting innovation and quality. ,…

SimBioSys Secures Third FDA Clearance for TumorSight™ Viz, Advancing AI-Powered Precision Surgery in Breast Cancer Care

Latest release introduces industry-leading AI performance, optimized workflow integration, and enhanced surgeon usability to streamline imaging-to-intervention planning , /PRNewswire/ — SimBioSys®, a clinical AI company…